A new trade agreement hammered out between the United States and China could boost the competitive positions of San Diego area medical technology companies, Scripps Health Chief Academic Officer Eric Topol, MD, told the U-T San Diego.
“One local example is Illumina competing with (Beijing Genomics Institute) in China,” Dr. Topol said. “Taking down the tariffs could help Illumina compete in what is a ginormous market.”
Dr. Topol directs the Scripps Translational Science Institute, which conducts clinical trials around genomic medicine and wireless health technology. San Diego-based Illumina is the world’s leading seller of DNA sequencing machines.
The new trade agreement, which involves 54 countries, must be ratified through the World Trade Organization.
Read the U-T San Diego article: Tariff Deal Could Help Local Tech Companies